Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

ENTREMED INC
Mes dernières consult.
Most popular
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Zuie Chin Huang, MBA522013Independent Director
Yue Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
James E. Goldschmidt, PhD-2016Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 29,124,243 48.3% 79,545 0.1% 48.3%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 16.7%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 14.1%
IDG Capital Partners Co., Ltd. 5,452,385 9.06%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 8.20%
Emerging Technology Partners LLC 2,312,677 3.84%
Wellington Shields Capital Management LLC 728,447 1.21%
Wellington Shields & Co. LLC (Investment Management) 505,474 0.84%
The Vanguard Group, Inc. 346,177 0.58%
European & Global Advisers LLP 343,500 0.57%
BlackRock Fund Advisors 265,108 0.44%
Sector Biotechnology & Medical Research - NEC
Connections : EntreMed Inc
IDG Technology Venture Investment, Inc.
Wuhan Kindstar Diagnostics Co., Ltd.
American-Sino OB/GYN Hospital
Human Longevity, Inc.
IDG Capital Partners Co., Ltd.
CVie Therapeutics Co. Ltd.
Allos Therapeutics, Inc.
Zenesis Ltd.
ImmunoVentis, Inc.
OMNI Pharmaceuticals (USA), Inc.
Circle Internet Financial Ltd.
Smooth Prosper Ltd.
Emerging Technology Partners LLC
GenScript Corp.
The UNLV Foundation
KPCB China Fund II LP
OriGene Technologies, Inc.
Crown Bioscience, Inc.
MithraGen, Inc.
Superdata Software Holdings Ltd.
WUPIMA, Inc.
IDG Technology Venture Investment IV LLC
Creditease Holdings Cayman Ltd.
Intradigm Corp.
MZ Investment Holdings Ltd.
National Foundation for Cancer Research
IDG Technology Venture Investment III LLC
Beijing Genetron Biotechnology Co. Ltd.
IDG Technology Venture Investments LP
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2017 People , Fundamentals and Ownership